Procoagulant Platelets: Further Details but Many More Questions.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

12 citing papers in PubMed.

1. Diabetes type 2: relationships between lysosomal exocytosis of circulating normal-sized platelets andAnnals of medicine · 2023
   Article
2. Platelet phosphatidylserine is the critical mediator of thrombosis in heparin-induced thrombocytopenia.Haematologica · 2023
   Article
3. S100A8/A9 drives the formation of procoagulant platelets through GPIbα.Blood · 2022
   Article
4. Cancer-related stroke: Exploring personalized therapy strategies.Brain and behavior · 2022
   Review
5. Another front in COVID-19's perfect storm.Blood · 2021
   Article
6. Thrombocytopathies: Not Just Aggregation Defects-The Clinical Relevance of Procoagulant Platelets.Journal of clinical medicine · 2021
   Review
7. Characterization of Procoagulant COAT Platelets in Patients with Glanzmann Thrombasthenia.International journal of molecular sciences · 2020
   Article
8. Protease Activity in Vascular Disease.Arteriosclerosis, thrombosis, and vascular biology · 2019
   Review
9. Thrombin Generation and Cancer: Contributors and Consequences.Cancers · 2019
   Review
10. Association of High Mobility Group Box-Protein 1 and Platelet Microparticles in Patients After Hematopoietic Stem Cell Transplantation.Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis
    Article
11. Decreased Thrombin Generation is Associated with Increased Thrombin Generation Biomarkers and Blood Cellular Indices in Pulmonary Embolism.Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis
    Article
12. Risk of Atherosclerosis Due to HMGB1-dependent Platelet-derived Microparticles in Patients with Type 2 Diabetes Mellitus.Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis
    Article

Corrections and comments

• Comment on
  Inner Mitochondrial Membrane Disruption Links Apoptotic and Agonist-Initiated Phosphatidylserine Externalization in Platelets.2017

Authors and funding

1 author.

Funding

No grant is acknowledged in the PubMed record.

Abstract

PubMed holds no abstract for this paper.

Indexed as